The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia

Patients' rationale for declining participation in a cancer-associated weight loss study

(2014) Tammy Wanger et al.   Journal of Cachexia Sarcopenia and Muscle

Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention

(2013) Liying Gu et al.   PLoS One

Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients

(2013) Ola Wallengren et al.   SUPPORTIVE CARE IN CANCER

Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87

(2012) Xin-Li Liu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature

(2011) Digant Gupta et al.   Nutrition Journal

The TRAF2 and TRAF6 expression in myomas and myometrium of women in reproduction and perimenopausal age.

(2010) Andrzej Plewka et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice

(2010) Pradyut K. Paul et al.   JOURNAL OF CELL BIOLOGY

The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting

(2008) Jeffrey A. Winkles   NATURE REVIEWS DRUG DISCOVERY